Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3872846)

Published in Vet J on August 17, 2013

Authors

D V L Rhodes1, C G Earnhart, T N Mather, P F M Meeus, R T Marconi

Author Affiliations

1: Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298-0678, USA.

Articles cited by this

Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50

Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15

Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol (1992) 7.82

Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun (1993) 4.16

The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50

Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics (1999) 3.46

Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli. Mol Microbiol (1992) 3.45

Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun (1999) 3.41

Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes. J Bacteriol (1993) 3.35

ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics (2004) 2.97

Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the Northeastern United States. Genetics (2002) 2.92

Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35

Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen. J Clin Microbiol (1993) 2.21

Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States: results of a national clinic-based serologic survey. Vet Parasitol (2008) 2.17

Identification of a third genomic group of Borrelia burgdorferi through signature nucleotide analysis and 16S rRNA sequence determination. J Gen Microbiol (1992) 1.91

Evolution of the Borrelia burgdorferi outer surface protein OspC. J Bacteriol (1995) 1.81

Identification of a protein in several Borrelia species which is related to OspC of the Lyme disease spirochetes. J Clin Microbiol (1993) 1.80

Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun (2005) 1.55

ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med (2006) 1.50

Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol (2005) 1.46

Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI. Infect Immun (2001) 1.41

Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection (1996) 1.24

Lyme borreliosis in dogs and humans in the USA. Trends Parasitol (2010) 1.22

Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease. Arch Dermatol (1999) 1.19

Population structure of the lyme borreliosis spirochete Borrelia burgdorferi in the western black-legged tick (Ixodes pacificus) in Northern California. Appl Environ Microbiol (2009) 1.18

Genetic diversity of Borrelia burgdorferi sensu stricto in Peromyscus leucopus, the primary reservoir of Lyme disease in a region of endemicity in southern Maryland. Appl Environ Microbiol (2006) 1.14

Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity. Microbes Infect (2006) 1.12

Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains. Vaccine (2006) 1.09

Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes. J Bacteriol (2001) 1.09

Demonstration of cotranscription and 1-methyl-3-nitroso-nitroguanidine induction of a 30-gene operon of Borrelia burgdorferi: evidence that the 32-kilobase circular plasmids are prophages. J Bacteriol (2005) 1.05

Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment. Mol Microbiol (2010) 1.01

Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One (2011) 1.00

OspC is potent plasminogen receptor on surface of Borrelia burgdorferi. J Biol Chem (2012) 1.00

Preferential protection of Borrelia burgdorferi sensu stricto by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis (2008) 1.00

An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences. Hum Vaccin (2007) 0.97

Lyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu stricto. Vet Clin North Am Small Anim Pract (2010) 0.97

OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine. Clin Vaccine Immunol (2007) 0.97

One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol (2010) 0.89

Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development. Clin Vaccine Immunol (2006) 0.88

Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens. Vaccine (2007) 0.87

Lyme disease in Rhode Island: three years of surveillance. Med Health R I (1996) 0.79

Articles by these authors

Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol (1987) 4.01

Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol (1998) 3.15

Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae). J Med Entomol (1987) 3.00

Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol (1995) 2.38

Concurrent Borrelia burgdorferi and Babesia microti infection in nymphal Ixodes dammini. J Clin Microbiol (1986) 2.17

Incompetence of deer as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg (1988) 1.96

Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection. Infect Immun (2000) 1.75

gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi. J Bacteriol (1994) 1.74

Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis. J Biol Chem (2000) 1.73

Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun (2003) 1.70

Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular-weight immunoreactive proteins. Infect Immun (1998) 1.50

Methods for evaluating Lyme disease risks using geographic information systems and geospatial analysis. J Med Entomol (1996) 1.46

Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI. Infect Immun (2001) 1.41

Seasonal variation of transmission risk of Lyme disease and human babesiosis. Am J Epidemiol (1987) 1.35

Comparative prevalence of Babesia microti and Borrelia burgdorferi in four populations of Ixodes dammini in eastern Massachusetts. Acta Trop (1986) 1.33

Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island. J Clin Microbiol (1997) 1.26

Demonstration of the genetic stability and temporal expression of select members of the lyme disease spirochete OspF protein family during infection in mice. Infect Immun (2001) 1.25

Genetic divergence and evolutionary instability in ospE-related members of the upstream homology box gene family in Borrelia burgdorferi sensu lato complex isolates. Infect Immun (1998) 1.24

Transovarially acquired Lyme disease spirochetes (Borrelia burgdorferi) in field-collected larval Ixodes dammini (Acari: Ixodidae). J Med Entomol (1986) 1.22

Variation in the size of the ospA-containing linear plasmid, but not the linear chromosome, among the three Borrelia species associated with Lyme disease. J Gen Microbiol (1993) 1.20

Tick cell culture isolation of an intracellular prokaryote from the tick Ixodes scapularis. J Invertebr Pathol (1996) 1.19

Identification and characterization of an intervening sequence within the 23S ribosomal RNA genes of Campylobacter jejuni. Mol Microbiol (1994) 1.14

Analysis of the organization of multicopy linear- and circular-plasmid-carried open reading frames in Borrelia burgdorferi sensu lato isolates. Infect Immun (1998) 1.13

Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes. J Bacteriol (2001) 1.09

Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals. Infect Immun (2006) 1.09

The bdr gene families of the Lyme disease and relapsing fever spirochetes: potential influence on biology, pathogenesis, and evolution. Emerg Infect Dis (2000) 1.08

Ixodes scapularis: salivary kininase activity is a metallo dipeptidyl carboxypeptidase. Exp Parasitol (1998) 1.05

Assessing the association between the geographic distribution of deer ticks and seropositivity rates to various tick-transmitted disease organisms in dogs. J Am Vet Med Assoc (2001) 1.04

Cloning and molecular characterization of a multicopy, linear plasmid-carried, repeat motif-containing gene from Borrelia turicatae, a causative agent of relapsing fever. J Bacteriol (1998) 1.04

Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice. Infect Immun (1997) 1.01

Analysis of the cellular localization of Bdr paralogs in Borrelia burgdorferi, a causative agent of lyme disease: evidence for functional diversity. J Bacteriol (2000) 1.01

Lyme disease and babesiosis: acaricide focused on potentially infected ticks. Am J Trop Med Hyg (1987) 0.99

Evolutionary and molecular analyses of the Borrelia bdr super gene family: delineation of distinct sub-families and demonstration of the genus wide conservation of putative functional domains, structural properties and repeat motifs. Microb Pathog (2000) 0.98

Molecular and immunological analyses of the Borrelia turicatae Bdr protein family. Infect Immun (2000) 0.96

Cloning and expression of the hup encoding a histone-like protein of Campylobacter jejuni. Gene (1994) 0.93

How much pilocarpine contaminates pilocarpine-induced tick saliva? Med Vet Entomol (2004) 0.93

Short-tailed shrews as reservoirs of the agents of Lyme disease and human babesiosis. J Parasitol (1990) 0.92

Identification of the primary mechanism of complement evasion by the periodontal pathogen, Treponema denticola. Mol Oral Microbiol (2010) 0.92

Seasonal variation in the capacity of the bank vole to infect larval ticks (Acari: Ixodidae) with the Lyme disease spirochete, Borrelia burgdorferi. J Med Entomol (1993) 0.90

Molecular signaling mechanisms of the periopathogen, Treponema denticola. J Dent Res (2011) 0.90

Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21. J Infect Dis (1995) 0.89

Host oyster tissue extracts modulate in vitro protease expression and cellular differentiation in the protozoan parasite, Perkinsus marinus. Parasitology (2003) 0.88

Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer. J Parasitol (2000) 0.87

Relative humidity and activity patterns of Ixodes scapularis (Acari: Ixodidae). J Med Entomol (2014) 0.85

Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Vet Ther (2000) 0.85

Diurnal detachment of immature deer ticks (Ixodes dammini) from nocturnal hosts. Am J Trop Med Hyg (1986) 0.85

Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis. J Clin Microbiol (1994) 0.85

Determining the duration of Ixodes scapularis (Acari: Ixodidae) attachment to tick-bite victims. J Med Entomol (1995) 0.84

Effect of host blood source on the gonotrophic cycle of Aedes triseriatus. Am J Trop Med Hyg (1983) 0.82

Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease. Mol Oral Microbiol (2014) 0.80

Lyme disease in Rhode Island: three years of surveillance. Med Health R I (1996) 0.79

Occurrence and distribution in Rhode Island of Hunterellus hookeri (Hymenoptera: Encyrtidae), a wasp parasitoid of Ixodes dammini. J Med Entomol (1993) 0.79

The Hpk2-Rrp2 two-component regulatory system of Treponema denticola: a potential regulator of environmental and adaptive responses. Mol Oral Microbiol (2010) 0.79

The Treponema denticola AtcR LytTR domain-containing response regulator interacts with three architecturally distinct promoter elements: implications for understanding the molecular signaling mechanisms that drive the progression of periodontal disease. Mol Oral Microbiol (2014) 0.78

Increased dissemination of dengue 2 virus in Aedes aegypti associated with concurrent ingestion of microfilariae of Brugia malayi. Am J Trop Med Hyg (1987) 0.78

Conditions for increased insemination rates in caged Aedes triseriatus (Diptera: Culicidae) reared from field-collected eggs. Am J Trop Med Hyg (1984) 0.78

Cloning and expression of the Borrelia burgdorferi lon gene. Gene (1997) 0.78

Experimental Babesia microti infection in golden hamsters: immunoglobulin G response and recovery from severe hemolytic anemia. J Parasitol (1996) 0.78

Sequence divergence in the Treponema denticola FhbB protein and its impact on factor H binding. Mol Oral Microbiol (2013) 0.77

Polymerase chain reaction detection efficiency of the human granulocytic ehrlichiosis agent (Rickettsiaceae: Ehrlichieae) in ticks (Acari: Ixodidae) is dependent on the DNA extraction method. J Med Entomol (1999) 0.75

A reverse transcriptase-polymerase chain reaction assay for detecting Highlands J virus. Avian Dis (2001) 0.75

Methods for control of tick vectors of Lyme borreliosis. Scand J Infect Dis Suppl (1991) 0.75

Dispersion of gravid Aedes triseriatus (Diptera: Culicidae) from woodlands into open terrain. J Med Entomol (1984) 0.75

Evaluation of host-targeted applications of permethrin for control of Borrelia-infected Ixodes ricinus (Acari: Ixodidae). Med Vet Entomol (1995) 0.75